- Ignacio Varela
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Patrick Tarpey
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Keiran Raine
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Dachuan Huang
(NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, 11 Hospital Drive)
- Choon Kiat Ong
(NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, 11 Hospital Drive)
- Philip Stephens
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Helen Davies
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- David Jones
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Meng-Lay Lin
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Jon Teague
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Graham Bignell
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Adam Butler
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Juok Cho
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Gillian L. Dalgliesh
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Danushka Galappaththige
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Chris Greenman
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Claire Hardy
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Mingming Jia
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Calli Latimer
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- King Wai Lau
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- John Marshall
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Stuart McLaren
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Andrew Menzies
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Laura Mudie
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Lucy Stebbings
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- David A. Largaespada
(Masonic Cancer Center, University of Minnesota)
- L. F. A. Wessels
(Bioinformatics and Statistics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands)
- Stephane Richard
(Génétique Oncologique EPHE-INSERM U753, Faculté de Médecine Paris-Sud and Institut de Cancérologie Gustave Roussy, 94805 Villejuif, France
Centre Expert National Cancer Rares INCa “PREDIR”, Service d’Urologie, Hôpital de Bicêtre, AP-HP, 94276 Le Kremlin-Bicêtre, France)
- Richard J. Kahnoski
(Spectrum Health Hospital)
- John Anema
(Spectrum Health Hospital)
- David A.Tuveson
(Li Ka Shing Centre, Cambridge Research Institute, Cancer Research UK, Robinson Way, Cambridge CB2 0RE, UK)
- Pedro A. Perez-Mancera
(Li Ka Shing Centre, Cambridge Research Institute, Cancer Research UK, Robinson Way, Cambridge CB2 0RE, UK)
- Ville Mustonen
(Bioinformatics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK)
- Andrej Fischer
(Bioinformatics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Institut für Theoretische Physik, Universität zu Köln, Zülpicherstrasse 77, 50937 Köln, Germany)
- David J. Adams
(Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK)
- Alistair Rust
(Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK)
- Waraporn Chan-on
(NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, 11 Hospital Drive)
- Chutima Subimerb
(NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, 11 Hospital Drive)
- Karl Dykema
(Laboratory of Computational Biology, Van Andel Research Institute)
- Kyle Furge
(Laboratory of Computational Biology, Van Andel Research Institute)
- Peter J. Campbell
(Cancer Genome Project, Wellcome Trust Sanger Institute)
- Bin Tean Teh
(NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, 11 Hospital Drive
Laboratory of Cancer Therapeutics, DUKE-NUS Graduate Medical School
Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan, 49503, USA)
- Michael R. Stratton
(Cancer Genome Project, Wellcome Trust Sanger Institute
Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK)
- P. Andrew Futreal
(Cancer Genome Project, Wellcome Trust Sanger Institute)